Tekla Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $7.14M | Hold |
219,025
| – | – | 0.28% | 70 |
|
|
2023
Q1 | $7.71M | Buy |
219,025
+143,886
| +191% | +$5.06M | 0.29% | 65 |
|
|
2022
Q4 | $3.44M | Hold |
75,139
| – | – | 0.13% | 88 |
|
|
2022
Q3 | $3.64M | Sell |
75,139
-44,759
| -37% | -$2.17M | 0.15% | 93 |
|
|
2022
Q2 | $4.71M | Hold |
119,898
| – | – | 0.19% | 89 |
|
|
2022
Q1 | $4.41M | Buy |
119,898
+27,027
| +29% | +$995K | 0.16% | 99 |
|
|
2021
Q4 | $4.23M | Buy |
+92,871
| New | +$4.23M | 0.14% | 105 |
|
|
2018
Q2 | – | Sell |
-137,797
| Closed | -$992K | – | 182 |
|
|
2018
Q1 | $992K | Sell |
137,797
-212,503
| -61% | -$1.53M | 0.04% | 158 |
|
|
2017
Q4 | $2.86M | Buy |
+350,300
| New | +$2.86M | 0.11% | 112 |
|